Items where authors include "Gansevoort, R.T."

Article

Bais, T., Meijer, E. orcid.org/0000-0001-7875-1793, Kramers, B.J. et al. (15 more authors) (2024) HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial. Trials, 25 (1). 120. ISSN 1745-6215

Taylor, J., Thomas, R., Metherall, P. et al. (15 more authors) (2023) An artificial intelligence generated automated algorithm to measure total kidney volume in ADPKD. Kidney International Reports. ISSN 2468-0249

Harskamp, L.R., Perez-Gomez, M.V. orcid.org/0000-0003-4558-5236, Heida, J.E. et al. (16 more authors) (2023) The association of urinary epidermal growth factors with ADPKD disease severity and progression. Nephrology Dialysis Transplantation. gfad050. ISSN 0931-0509

Gansevoort, R.T., Hariri, A., Minini, P. et al. (11 more authors) (2022) Venglustat, a novel glucosylceramide synthase inhibitor, in patients at risk of rapidly progressing ADPKD: primary results of a double-blind, placebo-controlled, phase 2/3 randomized clinical trial. American Journal of Kidney Diseases. S0272-6386(22)01079. ISSN 0272-6386

Winterbottom, J., Simms, R.J., Caroli, A. et al. (10 more authors) (2022) Flank pain has a significant adverse impact on quality of life in ADPKD: the CYSTic-QoL study. Clinical Kidney Journal, 15 (11). pp. 2063-2071. ISSN 2048-8505

Ortiz, A., Wanner, C., Gansevoort, R. et al. (12 more authors) (2022) Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association. European Journal of Preventive Cardiology. ISSN 2047-4873

Perrone, R.D., Hariri, A., Minini, P. et al. (10 more authors) (2022) The STAGED-PKD 2-stage adaptive study with a patient enrichment strategy and treatment effect modeling for improved study design efficiency in patients with ADPKD. Kidney Medicine, 4 (10). 100538. ISSN 2590-0595

Müller, R.-U., Lianne Messchendorp, A., Birn, H. et al. (20 more authors) (2022) An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. Kidneys, 11 (1). pp. 37-39. ISSN 2307-1257

Müller, R.-U., Messchendorp, A.L., Birn, H. et al. (20 more authors) (2022) An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. Nephrology Dialysis Transplantation, 37 (5). pp. 825-839. ISSN 0931-0509

Ong, A.C.M. orcid.org/0000-0002-7211-5400 and Gansevoort, R.T. (2021) TAMEing ADPKD with metformin : safe and effective? Kidney International, 100 (3). pp. 513-515. ISSN 0085-2538

Cho, Y., Tong, A., Craig, J.C. et al. (28 more authors) (2021) Establishing a core outcome set for autosomal dominant polycystic kidney disease : report of the Standardized Outcomes in Nephrology–Polycystic Kidney Disease (SONG-PKD) consensus workshop. American Journal of Kidney Diseases, 77 (2). pp. 255-263. ISSN 0272-6386

Logeman, C., Cho, Y., Sautenet, B. et al. (27 more authors) (2020) ‘A sword of Damocles’ : patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study. BMJ Open, 10 (10). e038005.

Cho, Y., Rangan, G., Logeman, C. et al. (25 more authors) (2020) Core outcome domains for trials in autosomal dominant polycystic kidney disease: An international Delphi survey. American Journal of Kidney Diseases, 76 (3). pp. 361-373. ISSN 0272-6386

Sautenet, B., Cho, Y., Gutman, T. et al. (15 more authors) (2020) Range and variability of outcomes reported in randomized trials conducted in patients with polycystic kidney disease: A systematic review. American Journal of Kidney Diseases, 76 (2). pp. 213-223. ISSN 0272-6386

Simms, R.J., Doshi, T., Metherall, P. et al. (7 more authors) (2019) A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease. European Radiology, 29 (8). pp. 4188-4197. ISSN 0938-7994

Harris, T., Sandford, R., de Coninck, B. et al. (17 more authors) (2018) European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD Forum and Multispecialist Roundtable participants. Nephrology Dialysis Transplantation, 33 (4). pp. 563-573. ISSN 0931-0509

Gansevoort, R.T., Arici, M., Benzing, T. et al. (18 more authors) (2016) Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice. Nephrology Dialysis Transplantation, 31 (3). pp. 337-348. ISSN 0931-0509